Trisha Millican

Trisha Millican is an accomplished financial executive with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Chief Financial Officer at Architect Therapeutics since March 2023, Trisha also holds positions as a member of the Board of Directors at ReCode Therapeutics and as a member of the Board of Managers at Life Science Cares San Diego. Prior roles include Chief Financial Officer at Metacrine, Inc. from 2015 to 2022, Senior Vice President of Finance and Acting CFO at Seragon Pharmaceuticals, and Vice President of Finance at Aragon Pharmaceuticals. Trisha has also served in senior financial roles at Zogenix Inc., Metabasis Therapeutics, and Discovery Partners International. Trisha holds a Bachelor of Science in Accounting from the University of San Diego, obtained between 1993 and 1995.